A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Incyte Corp stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 10,068 shares of INCY stock, worth $594,213. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,068
Previous 10,568 4.73%
Holding current value
$594,213
Previous $664,000 13.55%
% of portfolio
0.01%
Previous 0.01%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$56.55 - $66.59 $28,275 - $33,295
-500 Reduced 4.73%
10,068 $574,000
Q4 2023

Feb 09, 2024

BUY
$52.16 - $64.19 $422,078 - $519,425
8,092 Added 326.82%
10,568 $664,000
Q2 2023

Aug 03, 2023

SELL
$60.95 - $75.51 $7.95 Million - $9.85 Million
-130,488 Reduced 98.14%
2,476 $154,000
Q1 2023

May 12, 2023

BUY
$70.23 - $86.01 $5.98 Million - $7.32 Million
85,151 Added 178.09%
132,964 $9.61 Million
Q4 2022

Feb 13, 2023

BUY
$67.18 - $84.11 $2.91 Million - $3.64 Million
43,292 Added 957.58%
47,813 $3.84 Million
Q3 2022

Nov 07, 2022

BUY
$66.18 - $82.86 $101,586 - $127,190
1,535 Added 51.41%
4,521 $301,000
Q1 2022

May 11, 2022

BUY
$66.02 - $79.71 $197,135 - $238,014
2,986 New
2,986 $237,000
Q4 2020

Feb 12, 2021

SELL
$80.74 - $97.7 $40,289 - $48,752
-499 Closed
0 $0
Q3 2020

Nov 09, 2020

BUY
$85.07 - $109.69 $42,449 - $54,735
499 New
499 $45,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $13.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Bi Asset Management Fondsmaeglerselskab A Portfolio

Follow Bi Asset Management Fondsmaeglerselskab A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.